A Phase 2 double blinded, randomised, placebo controlled dose-finding study to evaluate the safety tolerability and efficacy of Volixibat potassium an apical sodium-dependant bile acid transport inhibitor (ASBTi) in adults with non-alcoholic steatohepatitis (NASH) (SHIRE Study)

1st February 2017 - ongoing


Specialism: Liver.

Team: Professor Guruprasad AithalDr Rob ScottDr Jane Chalmers.

Photo Name Bio
guruprasad-aithal Professor Guruprasad Aithal Professor Aithal has been a Consultant Hepatobiliary Physician at Nottingham University Hospitals NHS trust since 2001. He is the Head of the NIHR Nottingham Digestive Diseases Biomedical Research Centre, and the Head of Division for the Nottingham…
dr-rob-scott Dr Rob Scott
Dr Jane Chalmers
Title Amount